Research programme: MicAbody antibodies - AvidBioticsAlternative Names: MicAbody™ proteins - AvidBiotics
Latest Information Update: 22 Sep 2017
Price : *
At a glance
- Originator AvidBiotics Corp.
- Class Antibodies; Antineoplastics; Antivirals
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
- Research Cytomegalovirus infections
Most Recent Events
- 12 Sep 2017 Early research in Cytomegalovirus infections in USA before September 2017 (AvidBiotics pipeline, September 2017)
- 12 Sep 2017 Preclinical trials in Cancer in USA before September 2017 (AvidBiotics pipeline, September 2017)